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The intestinal mucosa is a  major host barrier  to foreign antigen entry.  Yet, 
little is known about specific cellular immune mechanisms of the gut-associated 
lymphoid tissues (GALT). Studies using human and murine GALT have dem- 
onstrated natural  killer (NK) and antibody-dependent, cell-mediated cytotoxic 
responses and  lectin-mediated cytotoxic activities  of intestinal  lamina  propria 
lymphocytes (LPL)  and  intraepithelial  lymphocytes (IEL)  (1-4).  Cytotoxic  T 
lymphocyte (CTL) responses to minor histocompatibility antigens and alloanti- 
gens have  also  been  demonstrated  using mesenteric lymph node and  Peyer's 
patch cells (5).  Considerably less is known about antigen-specific cytotoxic re- 
sponses of the IEL and  LPL (6).  For this reason, we have examined cytotoxic 
responses of murine gut IEL after local and systemic priming with alloantigens. 
Our results detail a  series of previously undescribed immunologic events that 
occur in  the intestinal  mucosa, but not in the spleen, in response to antigen. 
Concomitant with the generation of a  specific cytotoxic response by gut IEL, 
additional cytotoxic effector populations are nonspecifically activated locally. 
Materials and Methods 
Mice.  8-12-wk-old female BALB/cBy mice were obtained from The Jackson Labora- 
tory, Bar Harbor, ME. 
Immunization  of Mice and Preparation  of Effector Cells.  Mice were injected intraperito- 
7  neally (i.p.) with  10  viable EL-4  thymoma  cells.  10  d  later, animals were  challenged 
intraperitoneally and  intragastrically (i.g.)with  107  EL-4  cells.  3  d  postchailenge, mice 
were sacrificed, the small intestine was removed and flushed of fecal material, and Peyer's 
patches were dissected out.  The intestine was opened and cut into 2-4-mm pieces and 
transferred to a beaker containing 25 ml of phosphate-buffered saline with 1 mM EDTA 
(PBS-EDTA). Tissues were stirred at 37°C  for 20  min.  Cells were collected and tissue 
fragments were stirred in fresh PBS-EDTA for an additional 20 min. Pooled cell suspen- 
sions were rapidly filtered through 300 mg of nylon wool in a  10-cc syringe, and recovered 
cells were washed twice in RPMI  1640 containing fetal calf serum (FCS). This procedure 
yielded 40-60  ×  106  lymphoid cells per mouse  with >95%  viability. Spleen cells were 
prepared by dissociation of the tissue with forceps and pipetting with a pasteur pipette. 
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Target Cell Lines and Cytotoxic  Assay.  EL-4, P815, and YAC- 1 cell lines were maintained 
in RPMI 1640 containing 10% FCS. Spleen cell blasts were prepared by culturing 2-4 x 
106 nucleated spleen cells for 3 d in 5 ml of RPMI 1640 containing 10% FCS and either 
3 t~g/ml concanavalin A (Con A) or 50 #g/mi lipopolysaccharide-B (LPS) (Escherichia coli 
055:B5;  Difco Laboratories, Inc., Detroit, MI). Cytotoxic assays were conducted in 96- 
well microtiter plates.  106 IEL, or dilutions, were added to wells in 100 t~l of RPMI 1640 
+  10% FCS (assay medium). 104 5'Cr-labeled target cells (EL-4, P815, YAC-1, or splenic 
blasts) were added to wells in 100 ~1 of assay medium and cultures were incubated for 4 
h at 37 °C in 5% CO~. The amount of 5~Cr present in cell-free supernatants was measured 
in an automatic gamma counter and the percent specific lysis was calculated as follows: 
Percent specific  lysis =  [(cpm release experimental group -  cpm spontaneous release)/ 
(cpm detergent release -  cpm spontaneous release)]  x  100. 
Cold Target Competition Assay.  50 t~l of 1 X 104 5~Cr-labeled P815 mastocytoma cells 
were mixed with 50 tA of 3 x  I04 unlabeled EL-4, P815, YAC-1, or SP2/0 cells. These 
were added to 1 x  106 or 5 x  105 gut IEL from EL-4 primed BALB/c mice. After 4 h 
incubation at 37 °C in 5% CO2, the amount of released 5'Cr was determined as described 
above. 
In Vivo Treatment of Mice with Anti-Asialo  GM-1 Antibody.  BALB/c mice were immu- 
nized with  107  EL-4  tumor cells by intraperitoneal injection.  10 d  later animals were 
challenged with 107 EL-4 i.p. and i.g. and injected intravenously with 100 #! of undiluted 
anti-asialo GM-1 antibody (Wako Pure Chemical Ind., Dallas,  TX).  3 d  postchallenge, 
animals were  sacrificed,  and  IEL and  splenic  lymphocytes were  tested  for  cytotoxic 
activities against 5~Cr-labeled EL-4, P815, and YAC-1 target cells. 
Results and Discussion 
BALB/c (H-2 d) mice were immunized with allogeneic EL-4 (H-2 b) thymoma 
cells as described in Materials and Methods.  Both gut and splenic lymphocytes 
from primed mice lysed EL-4 (antigen-specific target) and YAC-1  (NK-sensitive 
target) (Fig. 1, A and C). However, unlike splenic lymphocytes, IEL from primed 
mice were highly cytotoxic for P815 mastocytoma cells (Fig. 1 C). Moreover, the 
anti-P815  and anti-YAC-1  activities of IEL from primed  mice appear  to have 
been generated during the antigen-specific response to EL-4, since normal IEL 
were  not cytotoxic for  P815  or YAC-1  (Fig.  1D).  Unlike splenic  lymphocytes 
(Fig. 1B), IEL from unprimed mice did not kill YAC-1  NK-sensitive targets (Fig. 
1 D).  It  appears  that  during an  antigen-specific response  within the  intestinal 
mucosa,  additional cytotoxic responses are generated locally to  levels that are 
not usually present in normal GALT. 
To define the immunologic specificity of gut IEL, EL-4-primed BALB/c mice 
were tested for cytotoxic activity against allogeneic and syngeneic target cells. 
IEL from EL-4-primed BALB/c mice did not lyse syngeneic BALB/c Con A- 
induced spleen cell blasts, but did lyse EL-4, P815,  and YAC-1  cells (Fig.  2A). 
Similarly, syngeneic BALB/c spleen cell blasts induced by LPS were not killed, 
whereas allogeneic LPS blasts from C57BL/6 mice were lysed (Fig. 2B). These 
experiments  demonstrate  that  the  nonspecific activation  of cytotoxic effector 
cells within the gut after antigen priming is an immune event that discriminates 
between foreign and self antigens. 
To  further  probe  the  requirements  for  the  nonspecific  activation  of gut 
cytotoxic responses,  mice  were  primed  with  allogeneic  spleen  cells,  i.e.,  cells 
bearing alloantigens expressed on non-tumor cells. This was done to rule out the 
possibility that cytotoxic responses of gut lymphocytes may reflect preferential KLEIN  AND  KAGNOFF  BRIEF  DEFINITIVE  REPORT  1933 
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FIGURE  1.  Cytotoxic responses of splenic lymphocytes from EL-4-primed (A) and unprimed 
(B) mice, and of gut IEL from EL-4-primed (C) and unprimed (D) mice when tested against 
~lCr-labeled EL-4 (O), P815 (Q), and YAC-1 (,) target cells. 
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FIGURE 2.  Cytotoxic activity of gut IEL from EL-4-primed BALB/c mice tested against EL- 
4 (O), P815 (O), YAC-1 (11) and BALB/c Con A-induced spleen cell blasts (r'l) (A); and against 
C57BL/6 (A)and BALB/c (r'l) LPS-induced spleen cell blasts (B). Cytotoxic activity of gut IEL 
from BALB/c mice primed with 10 ~ C57BL/6 allogeneic spleen cells tested against EL-4 (O), 
P815 (O), and YAC-1 (11) target cells (C). 1934  KLEIN AND  KAGNOFF  BRIEF  DEFINITIVE REPORT 
recognition of tumor antigens shared by EL-4, P815, and YAC-1. BALB/c mice 
were immunized intraperitoneally with 107 freshly isolated C57BL/6 spleen cells 
suspended in unsupplemented RPMI  1640. Although gut IEL from those mice 
show a  slight preference for killing of EL-4 cells, YAC-1  and P815  cells were 
also lysed (Fig. 2 C), indicating that the activation of multiple cytotoxic responses 
within the gut is not limited to antigen presentation via tumor cells. 
Since YAC-1  and  P815  cells are known  (7,  8)  to  be susceptible  to  lysis by 
murine  NK  and  spontaneous  cytotoxic  (SC)  cells,  respectively,  studies  were 
undertaken to determine whether NK and SC activities account for YAC-1 and 
P815 killing by gut IEL from primed mice, and if so, whether one or more than 
one effector population is present. It has been reported (9) that cloned antigen- 
specific CTL lines, when maintained in medium containing high levels of inter- 
leukin 2 (IL-2) can express NK surface antigens and NK-like cytotoxic activities. 
Other studies have reported the acquisition of multiple cytotoxic specificities in 
CTL  miniclones derived by micromanipulation (10)  or by limit dilution  (11). 
Thus, the appearance of multiple cytotoxic activities within the gut of primed 
mice could reflect a single effector population that is responsible for the killing 
of YAC-1, P815, and EL-4 cells. Alternatively, several effector populations may 
be activated locally within the gut of primed mice.  Recently (12),  it has been 
reported that memory CTL can be induced to express cytotoxic function when 
cultured with IL-2 in the absence of antigen. 
Two  experimental  approaches  were  used  to  define  the  type(s) of effector 
populations activated within the intestinal mucosa. The first approach was based 
on the awareness that in vivo treatment of mice with anti-asialo GM-1 antibody 
depletes NK, but not CTL, activity (13). EL-4-primed BALB/c mice were injected 
intravenously with  100 ~1 of undiluted anti-asialo GM-1  antibody 3 d  before a 
cytotoxic assay. Antibody treatment completely abrogated YAC-1 killing by both 
splenic and gut lymphocytes (Fig.  3), indicating that NK cells were responsible 
for those activities.  However, anti-EL-4  and anti-P815  responses of IEL,  and 
anti-EL-4 killing by spleen cells, were retained in antibody-treated mice. 
A second group of experiments used cold target competition studies to char- 
acterize cytotoxic cells responsible  for anti-P815  activity of IEL from primed 
mice. SC cells are known (8) to lyse P815 and SP2/O cells, another SC-susceptible 
cell line, but not EL-4 or YAC-1 cells. IEL from BALB/c mice primed with EL- 
4  were tested for their ability to lyse ~Cr-labeled P815 cells in the presence of 
unlabeled  EL-4,  YAC-1,  P815,  or  SP2/O.  Neither EL-4  nor YAC-1  blocked 
P815 killing, whereas both SP2/O and P815 effectively competed for the killing 
of P815 by IEL (Table I). These data, in conjunction with the above experiment, 
suggest  that  discrete  cytotoxic effector populations  are  activated  within  the 
intestinal mucosa during an antigen-specific response. 
We consider the findings described here to be highly important with respect 
to immune defense mechanisms within the GALT. In the case of enteric infec- 
tion, the nonspecific recruitment of unrelated immune effector cells may prevent 
the establishment of secondary opportunistic infections. A mechanism of immu- 
nity  such  as  this  would  be  particularly  relevant  within  the  GALT  since  the 
intestinal mucosa, unlike the spleen, is perpetually exposed to numerous envi- 
ronmental  pathogens.  Although  the  mechanisms  by  which  gut  cytotoxic re- KLEIN  AND  KAGNOFF  BRIEF  DEFINITIVE  REPORT  1935 
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FIGURE  3.  Abrogation of NK cytotoxic activity in  mice after in  vivo treatment with anti- 
asialo GM-1  antibody. Gut  IEL (A) and splenic lymphocytes (B) from EL-4-primed BALB/c 
antibody-treated mice were tested for cytotoxic activity against EL-4 (O), P815 (O), and YAC- 
1 (It) target ceils. 
TABLE  1 
Cold Target Competition ofP815 Killing by Gut IEL 
~Cr-  Percent specific lysis of P815 in presence of cold 
labeled  E/T*  target competitor* 
target  ratio 
cell  None  EL-4  YAC-1  P815  SP2/0 
P815  100:1  71  74  66  20  28 
50:1  32  25  17  0  0 
* Ratio of gut I EL effector cells to 51Cr-labeled P815 target cells. 
* Unlabeled target cells were added to ~Cr-labeled P815 at a ratio of 3:1. 
sponses are controlled have not been determined as yet, regulation may be under 
the influence of lymphokines elaborated during the course of an antigen-specific 
response. Our data further define the types of cytotoxic cells that make up the 
IEL, demonstrating the simultaneous appearance of three distinct effector pop- 
ulations: cytotoxic T  lymphocytes, natural killer cells, and spontaneous cytotoxic 
cells. Finally, the findings reported here describing the in vivo activation of NK 
and SC responses correlate with recent studies (9, 10,  14, 15) demonstrating the 
generation of these activities in vitro using human and murine CTL. 
Summary 
We have examined cytotoxic responses of lymphocytes derived from the gut 
epithelium of mice primed systemically and enterically with alloantigens.  Both 
gut intraepithelial (IEL) and splenic lymphocytes from alioantigen-primed mice 
were found to contain antigen-specific cytotoxic T  cell activity. However, after 
priming, gut IEL also developed high levels of natural killer and spontaneous 
cytotoxic cell activities. We suggest that this nonspecific activation of additional 
cytotoxic effector populations during an antigen-specific response is an important 
host immune defense within the intestinal mucosa. 
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